On the way to mass production: perovskite silicon tandem cells
The cluster facility operated at HZB allows to produce large-area perovskite/silicon tandem solar cells. This facility, the only one of its kind in the world, helps to develop new industry-related processes, materials and solar cells. © B. Stannowski / HZB
In order to transfer tandem solar cells from laboratory scale to production, HZB is cooperating with the solar module manufacturer Meyer Burger, which has great expertise in heterojunction technology (HJT) for silicon modules. Within the framework of this cooperation, mass production-ready silicon bottom cells based on heterojunction technology are to be combined with a top cell based on perovskite technology.
Meyer Burger is a manufacturer of high-quality solar modules based on silicon heterojunction technology (HJT). Meyer Burger's research and development team has already developed HJT cells in recent years together with Bernd Stannowski's team at the Helmholtz-Zentrum Berlin.
The HZB has great expertise in the field of perovskite solar cells. Recently, laboratory tandem solar cells combining heterojunction and perovskite have achieved record efficiencies of over 31 percent, largely due to the work of Steve Albrecht's group. However, such record-breaking tandem cells have only the laboratory-standard areas of 1 cm² and are partly produced with processes that are not scalable.
"We are therefore delighted to be cooperating with Meyer Burger to transfer this fantastic technology into application," says Bernd Stannowski, who heads the cooperation at HZB. A new cluster facility (KOALA) will also be used. This globally unique facility, funded by the German Federal Ministry of Economics and Climate Protection (BMWK) and the Federal Ministry of Education and Research (BMBF), makes it possible to produce perovskite/silicon tandem solar cells in a vacuum on industry-standard large wafers.
"Meyer Burger manufactures in Europe and thus creates high-quality jobs. In doing so, the company is exploiting technologies that were developed in Europe," says Rutger Schlatmann, director of the Photovoltaics Competence Centre Berlin (PVcomB) at HZB. The new cooperation agreement is set to run for three years.
- Green hydrogen: MXenes shows talent as catalyst for oxygen evolutionThe MXene class of materials has many talents. An international team led by HZB chemist Michelle Browne has now demonstrated that MXenes, properly functionalised, are excellent catalysts for the oxygen evolution reaction in electrolytic water splitting. They are more stable and efficient than the best metal oxide catalysts currently available. The team is now extensively characterising these MXene catalysts for water splitting at the Berlin X-ray source BESSY II and Soleil Synchrotron in France.
- SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beerThe first sign of spoilage in many food products is the formation of free radicals, which reduces the shelf-life and the overall quality of the food. Until now, the detection of these molecules has been very costly for the food companies. Researchers at HZB and the University of Stuttgart have developed a portable, small and inexpensive 'EPR on a chip' sensor that can detect free radicals even at very low concentrations. They are now working to set up a spin-off company, supported by the EXIST research transfer programme of the German Federal Ministry of Economics and Climate Protection. The EPRoC sensor will initially be used in the production of olive oil and beer to ensure the quality of these products.
- Review on ocular particle therapy (OPT) by international expertsA team of leading experts in medical physics, physics and radiotherapy, including HZB physicist Prof. Andrea Denker and Charité medical physicist Dr Jens Heufelder, has published a review article on ocular particle therapy. The article appeared in the Red Journal, one of the most prestigious journals in the field. It outlines the special features of this form of eye therapy, explains the state of the art and current research priorities, provides recommendations for the delivery of radiotherapy and gives an outlook on future developments.